8-K: Knowles Corporation Reports Q1 2025 Financial Results, Provides Q2 2025 Outlook

Knowles Corporation announces Q1 2025 results with revenues at the high end of guidance and provides a positive outlook for Q2 2025 with expected year-over-year revenue growth.

Summary

• Knowles Corporation reported its Q1 2025 financial results on April 24, 2025.
• Revenues from continuing operations were $132.2 million, at the high end of the guided range.
• Net cash from operations exceeded the high end of the guided range.
• Non-GAAP diluted earnings per share from continuing operations were $0.18, at the midpoint of the guided range.
• The company expects Q2 2025 revenues to be between $135 million and $145 million, representing a 4% year-over-year increase.
• GAAP diluted earnings per share for Q2 2025 are projected to be $0.11 to $0.15, with non-GAAP diluted earnings per share expected to be $0.21 to $0.25.
• Net cash provided by operating activities for Q2 is expected to be $10 to $20 million.
• Knowles repurchased $5 million of shares and reduced debt by $15 million in Q1 2025.
• The company anticipates another year of strong cash generation in 2025.
• An Investor Day is scheduled for May 13th to provide details on plans for 2025 and beyond.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The company met expectations for revenue and EPS, and anticipates growth in the next quarter. However, there are some concerns about macro-economic factors and some segments underperforming.

Positives

• Q1 2025 revenues were at the high end of the guided range.
• Net cash from operations exceeded the high end of the guided range.
• Non-GAAP diluted EPS was at the midpoint of the guided range.
• Q2 2025 revenue is expected to increase by 4% year-over-year.
• Precision Devices segment is seeing increased order activity and backlog.
• MedTech and Specialty Audio business is performing as expected.
• The company repurchased $5 million of shares and reduced debt by $15 million in Q1 2025.
• Knowles anticipates another year of strong cash generation in 2025.
• Adjusted EBITDA margins for MedTech & Specialty Audio are expected to improve sequentially, targeting low 40% range for full year 2025.

Negatives

• GAAP Net loss was $(2.0) million for Q1 2025.
• Q1 2025 revenues were slightly down from a year ago.
• MedTech & Specialty Audio adjusted EBITDA margins were down 450 bps year over year.
• Precision Devices revenue was down year over year, attributed to production challenges in the Specialty Film line.

Risks

• Macro level uncertainty due to tariffs could impact demand.
• The company faces risks related to fluctuations in stock market price, operating results, and cash flows.
• Quality issues in products and increasing inventories ahead of customer orders pose risks.
• Global economic instability, including inflation and geopolitical uncertainties, could have negative impacts.
• Changes in laws and regulations could affect the company's ability to offer products or services.
• Cybersecurity incidents could disrupt operations.
• Increases in the costs of critical raw materials and components could impact profitability.
• Dependence on a limited number of large customers presents a risk.
• Escalating international trade tensions and trade wars could negatively affect the company.
• Fluctuations in commodity prices, particularly for precious metals, could impact manufacturing costs.

Future Outlook

Knowles expects Q2 2025 revenues to be between $135 million and $145 million, representing a 4% year-over-year increase, with GAAP diluted earnings per share of $0.11 to $0.15 and non-GAAP diluted earnings per share of $0.21 to $0.25. Net cash provided by operating activities for Q2 is expected to be $10 to $20 million.

Management Comments

• 'I am pleased we completed the first quarter of 2025 with revenues at the high end of our guided range, cash provided by operating activities above our guided range, and non-GAAP diluted EPS from continuing operations at the mid-point of our guided range,' commented Jeffrey Niew, President, and CEO of Knowles.
• Mr. Niew stated that the revenue outlook for the second quarter represents sequential and year over year growth of 6% and 4%, respectively.
• Mr. Niew noted that the Precision Devices segment continues to experience increased order activity and backlog in most end markets while the MedTech and Specialty Audio business continues to perform at expectations.
• Mr. Niew expressed increasing confidence that Knowles will see year over year growth for 2025 across its businesses, despite macro level uncertainty due to tariffs.

Industry Context

Knowles operates in the specialty electronic components industry, serving innovative technologies in medtech, defense, and industrial markets. The company's performance is influenced by factors such as global economic conditions, trade tensions, and competition. The focus on non-GAAP measures suggests a drive to highlight core operational performance amidst various market fluctuations.

Comparison to Industry Standards

• It's difficult to provide a precise comparison without knowing the specific competitors and their Q1 2025 results.
• However, companies like Murata, TDK, and STMicroelectronics are key players in similar markets.
• Comparing Knowles' revenue growth, profitability margins, and cash flow generation against these companies' results would provide a more comprehensive assessment.
• For example, if Murata reported a 5% revenue growth in their comparable segment, Knowles' 4% projected growth would be slightly below the industry benchmark.
• Similarly, comparing Knowles' adjusted EBITDA margin of 20.2% to the average EBITDA margins of its peers would offer insights into its relative profitability.

Stakeholder Impact

• Shareholders can expect continued share repurchases and debt reduction.
• Employees can anticipate stable operations and potential growth opportunities.
• Customers can expect continued innovation and reliable supply of electronic components.
• Suppliers can expect continued business relationships and timely payments.
• Creditors can expect continued debt repayment and strong cash generation.

Next Steps

• The company will hold an Investor Day on May 13th to provide details on plans for 2025 and beyond.
• Knowles will continue to focus on improving profitability and cash generation.
• The company will monitor macro level uncertainty due to tariffs and adjust strategies as needed.

Key Dates

Keywords

financial results, revenues, earnings, Knowles Corporation, MedTech, Precision Devices, EBITDA, EPS, guidance, components